Please login to the form below

Not currently logged in
Email:
Password:

Senior changes at Merck KGaA

New head of controlling for its healthcare business

Merck KGaA, Andreas Stickler Germany's Merck KGaA has announced changes to its senior financial team for its healthcare operations.

Andreas Stickler (pictured top right) has been appointed as new head of controlling of the healthcare business sector where he will be responsible for the operations of Merck's pharma division Merck Serono, its consumer health business, biosmilars and allergy subsidiary Allergopharma.

Stickler is a 12-year veteran of Merck and has been head of mergers and acquisitions since 2008, leading the takeover of Millipore in 2010. He previously worked at Degussa, Aventis and Hoechst.

Merck 
KGaA, Roman WerthAnother Merck employee Roman Morten Werth (pictured bottom right) will assume Stickler's former position as head of mergers and acquisitions, a department he has been part of since joining Merck in 2008. He was previously manager of mergers and acquisitions for technology firm Siemens.

Merck's chief financial officer Marcus Kuhnert said: “We're delighted that two key positions in our finance function will be filled with internal managers who bring the experience and the track record to ensure quality and continuity alike.”

 

2nd February 2015

From: PME

Share

Tags

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
Onyx Health Ltd

Onyx Health is a healthcare communications and PR agency based in the North East of England, but with a national...

Latest intelligence

The other side of … rheumatoid arthritis
For Georgie, patient activation fuelled her motivation to find life without pain. So when blood tests came back normal, she felt confident to pursue referral until RA was confirmed......
How to lessen site burden with a targeted patient recruitment strategy
Picture this: you’ve created your patient recruitment strategy and you find more and more patients are undertaking the pre-screening, you probably think – success! But then you find out, getting...
Peter Howarth
Exploring the potential of eosinophils
GSK’s Peter Howarth talks about the emerging research that suggests there is a varied role for eosinophils...

Infographics